Home Sulfos 1H-Indole-1-sulfonamide,2,3-dihydro-(9CI)

1H-Indole-1-sulfonamide,2,3-dihydro-(9CI)

CAS No.:
34917-77-6
Catalog Number:
AG00CXH1
Molecular Formula:
C8H10N2O2S
Molecular Weight:
198.2422
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG00CXH1
Chemical Name:
1H-Indole-1-sulfonamide,2,3-dihydro-(9CI)
CAS Number:
34917-77-6
Molecular Formula:
C8H10N2O2S
Molecular Weight:
198.2422
MDL Number:
MFCD11205200
IUPAC Name:
2,3-dihydroindole-1-sulfonamide
InChI:
InChI=1S/C8H10N2O2S/c9-13(11,12)10-6-5-7-3-1-2-4-8(7)10/h1-4H,5-6H2,(H2,9,11,12)
InChI Key:
IWPJHISUYDXHGJ-UHFFFAOYSA-N
SMILES:
NS(=O)(=O)N1CCc2c1cccc2
Properties
Complexity:
283  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
198.046g/mol
Formal Charge:
0
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
198.24g/mol
Monoisotopic Mass:
198.046g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
71.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.4  
Literature
Title Journal
BPR1K653, a novel Aurora kinase inhibitor, exhibits potent anti-proliferative activity in MDR1 (P-gp170)-mediated multidrug-resistant cancer cells. PloS one 20110101
A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule. The Journal of pharmacology and experimental therapeutics 20071001
Properties